Rocket, Lab

Rocket Lab Hits $200M Revenue but Stock Tumbles 15%: The Double Whammy of a Rival's Explosion and an $18M Insider Sell-Off

02.06.2026 - 16:56:25 | boerse-global.de

Rocket Lab's Q1 revenue surged to $200.3M, but shares fell 14.7% after Blue Origin's engine test explosion, insider selling, and tempered SpaceX IPO expectations.

Rocket Lab Hits $200M Revenue but Stock Tumbles 15%: The Double Whammy of a Rival's Explosion and an $18M Insider Sell-Off - Bild: ĂĽber boerse-global.de
Rocket Lab Hits $200M Revenue but Stock Tumbles 15%: The Double Whammy of a Rival's Explosion and an $18M Insider Sell-Off - Bild: ĂĽber boerse-global.de

Rocket Lab delivered its best-ever quarterly results, with revenue surging past $200 million for the first time. But investors responded by hammering the stock 14.7% lower on Monday, wiping out a chunk of the stellar gains amassed over the previous month.

The immediate catalyst was a dramatic engine test failure at Blue Origin. The New Glenn rocket's test stand explosion in Florida, registering as a magnitude 2.5 earthquake, sent shockwaves through the space sector, dragging down peers such as Planet Labs and Intuitive Machines. Rocket Lab bore the brunt, as the incident resurrected concerns about the inherent risks of rocketry.

Compounding the sector-wide anxiety, a wave of insider profit-taking hit the wires. Director Alexander R. Slusky unloaded 60,000 shares worth roughly $9 million, part of a broader sell-off by four insiders that totaled $18 million. The timing—coming just days after the stock had posted eight consecutive all-time highs in May—made the pullback feel ripe for a correction.

Should investors sell immediately? Or is it worth buying Rocket Lab USA?

Adding to the noise, expectations around a potential SpaceX initial public offering began to waver. Rocket Lab's recent surge had been partly fueled by hopes that a SpaceX listing would lift the entire space industry. But reports suggesting a lower valuation target of around $1.8 trillion—down from earlier whispers of over $2 trillion—tempered that enthusiasm. With SpaceX reportedly set to begin marketing on June 4 and pricing around June 11, investors may be taking profits ahead of a less bullish-than-expected debut.

None of this alters the underlying operational momentum. Rocket Lab's fiscal first-quarter revenue hit $200.3 million, a 63.5% year-over-year leap, while its order backlog swelled past $2.2 billion. The company successfully passed a System Requirements Review for a Space Development Agency satellite program worth over $1.3 billion in total contracts. And the acquisition of Motiv Space Systems, now rebranded as Rocket Lab Robotics, brings Mars-proven robotic technology in-house, strengthening its capability to serve NASA missions.

Looking ahead, all eyes are on the Neutron rocket, a medium-lift vehicle slated for its debut at the end of 2026. That project will be key to unlocking the lucrative satellite constellation market, but success is far from guaranteed. Meanwhile, the stock's price-to-sales ratio of 48—based on analyst forecasts—demands continued high growth and a supportive sector environment, both of which remain uncertain.

Despite Monday's drubbing, Rocket Lab shares are still up roughly 61% year-to-date and have more than quadrupled over the past twelve months. The sell-off may be a healthy reset after a euphoric run, but it also underscores how quickly sentiment can shift in a fledgling industry where a single mishap can rattle confidence across the board.

Ad

Rocket Lab USA Stock: New Analysis - 2 June

Fresh Rocket Lab USA information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Rocket Lab USA analysis...

en | US7731221062 | ROCKET | boerse | 69471664 |